Theravance to Report First Quarter 2013 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Theravance to Report First Quarter 2013 Financial Results on April 25, 2013

SOUTH SAN FRANCISCO, CA--(Marketwired - Apr 11, 2013) - Theravance, Inc. ( NASDAQ : THRX ) announced today that it will release financial results for the period ended March 31, 2013 after market close on Thursday, April 25, 2013. 

An accompanying conference call will be held at 5:00 p.m. Eastern Daylight Time. To participate in the live call by telephone, please dial (877) 837-3908 from the U.S., or (973) 890-8166 for international callers. Those interested in listening to the conference call live via the internet may do so by visiting Theravance's web site at www.theravance.com . To listen to the live call via the internet, please go to the web site 15 minutes prior to its start to register, download, and install any necessary audio software.

A replay of the conference call will be available on Theravance's web site for 30 days through May 25, 2013. An audio replay will also be available through 11:59 p.m. Eastern Daylight Time on May 2, 2013 by dialing (855) 859-2056 from the U.S., or (404) 537-3406 for international callers, and entering confirmation code 21878794.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Theravance's key programs include: RELVAR™ or BREO™ (FF/VI), ANORO™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta 2 Agonist), each partnered with GlaxoSmithKline plc, and its oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. For more information, please visit Theravance's web site at www.theravance.com .

THERAVANCE®, the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of Theravance, Inc.

RELVAR™ or BREO™ (FF/VI) and ANORO™ (UMEC/VI) are investigational medicines and are not currently approved anywhere in the world. RELVAR™, BREO™ and ANORO™ are trademarks of the GlaxoSmithKline group of companies. The use of these brand names has not yet been approved by any regulatory authority.

(THRX-F)

Contact Information: Michael W. Aguiar Senior Vice President and Chief Financial Officer 650-808-4100 investor.relations@theravance.com

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AgriBank's Q3 Performance Shows Solid Growth in 2026

Updated Category News Views 103

AgriBank's Third Quarter Triumph Let me tell you, the folks at AgriBank have reason to crack open some celebratory cider this quarter. They're sitting pretty with a robust third quarter, reporting a net income of $910.9 million for the first nine months of 2026. That's no small potatoes, especially when you're surpassing targets like their 58 basis points return on...

Continue Reading
Tetragon Declares Dividend Amidst Regulation Challenges

Updated Category News Views 7

What Keeps Investors on Their Toes Tetragon Financial Group is ringing the dividend bell again—a solid 12 cents a share coming your way. But don't just kick your feet up and watch the cash roll in; there's a tangle of juicy tidbits and regulatory strings attached that make this more than your run-of-the-mill payout announcement. A Look at the Dividend Breakdown For...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 81

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
AI in Finance: Hidden Work Costs Firms Productivity

Updated Category News Views 97

AI's Unseen Burden on Finance Teams Ah, the promise of AI in finance—where's the catch, right? Well, turns out the burden lies with the finance pros themselves. You pour AI over broken, scattered data systems, and you're in for a world of headaches. Accounting Seed's latest research paints a gritty picture of what's happening on the ground in small and midsize...

Continue Reading
Geographic Solutions' New AI-Integrative Workforce Tool Unveiled

Updated Category News Views 89

Revamping Employment Landscapes with AI Geographic Solutions has just rolled out their latest powerhouse, Version 25 of the VOS Sapphire AI+, and let me tell you, it's got bells and whistles that could make even the savviest techie raise an eyebrow. This isn't just another software update; it's a full-bodied attempt to inject a little 21st-century magic into the workforce...

Continue Reading
Duolingo Faces Securities Fraud Suit: Key Takeaways

Updated Category News Views 26

The Blunt Reality Behind Duolingo’s 25.49% Stock Dive You ever wake up, coffee in hand, scrolling through financials, and get hit with that gut-drop feeling? That's where Duolingo investors are after a staggering 25.49% stock drop. It's like watching a slow-motion train wreck from May 2, 2025, to February 26, 2026, capped off by a securities class action suit. If you...

Continue Reading
CorelDRAW's Flexibility: A Designer's One-Time Buy?

Updated Category News Views 33

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

Continue Reading
Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 36

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Tata Power Faces Enforcement Order for $650M Debt

Updated Category News Views 82

Tata's Troubles Escalate Grab a cup of coffee, folks, because this is one rollercoaster of a story that every investor needs to have on their radar. We're talking about Singapore courts coming down on Tata Power like a freight train, with enforcement orders that feel like a page out of a high-stakes drama. The Gavel Drops: What's Happening? The court in Singapore has...

Continue Reading
Triller's Bumpy Ride: Legal Woes and Investor Action

Updated Category News Views 31

Triller's Stock Roller Coaster Ah, Triller Group Inc., a name that might've gotten you excited once, but now it's like a bad Hollywood sequel. Picture this: you're holding onto shares like a rookie chilling in the shark-infested waters, and now they're caught in a swirling mess of legal jazz and stock tumbles. It's not pretty, folks. We're talking about the whole nine...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Aon PLC's Market Position and Short Interest

Updated Category News Views 179

Aon PLC's Current Market Performance Aon PLC (NYSE:AON) has seen a notable shift in its market dynamics. Recent reports indicate that the company's short interest as a percentage of float has reduced by 3.0%. Currently, approximately 2.08 million shares are sold short, representing about 0.97% of its float. This statistic sheds light on the trading behavior surrounding...

Continue Reading
Amazon Teams Up with New York Times in $25 Million AI Deal

Updated Category News Views 178

Amazon Secures Partnership with The New York Times Amazon.com (NASDAQ: AMZN) has signed a landmark multiyear content licensing deal with The New York Times (NYSE: NYT), committing to pay between $20 million and $25 million annually. This innovative agreement marks a significant moment as both companies navigate the evolving landscape of digital journalism and artificial...

Continue Reading
Consumers Energy Announces Quarterly Dividend on Preferred Stock

Updated Category News Views 159

Consumers Energy Declares Dividend on Preferred Stock Consumers Energy, a leading utility provider and principal subsidiary of CMS Energy, has recently announced an important quarterly dividend on its preferred stock. This decision reflects the company’s ongoing commitment to rewarding its shareholders. Details of the Declared Dividend The Board of Directors has set the...

Continue Reading
Discover the New PicoPlay Series from JMGO for Portable Fun

Updated Category News Views 235

Introducing the Innovative PicoPlay Series JMGO has recently introduced a remarkable new line of portable projectors known as the PicoPlay series. These coffee-cup-sized devices are designed with the modern user in mind, combining advanced technology and user-friendly features for an unparalleled viewing experience. Perfect for streaming, social gatherings, and mobility,...

Continue Reading
MT Højgaard to Construct Major UNICEF Warehouse in Copenhagen

Updated Category News Views 219

MT Højgaard Danmark Wins Tender for UNICEF's New Warehouse MT Højgaard Holding’s business unit, MT Højgaard Danmark, has secured a significant contract for the construction of what will be the largest central warehouse for humanitarian aid. This facility will be dedicated to the UN’s children’s fund, UNICEF, with a total contract value of DKK 1.66 billion....

Continue Reading